GraniteShares YieldBOOST Biotech ETF (BIOY) Dividend Yield, History & Forecast

GraniteShares YieldBOOST Biotech ETF (BIOY) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 32.81% ($6.31 per share annually (TTM)). The most recent ex-dividend date was October 30, 2026, with payment scheduled for November 3, 2026. market capitalization is approximately $613,469. Review BIOY dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

BIOY fund composition

It charges an expense ratio of 14.98%, and manages $1.6M.

BIOY runs a derivative strategy and reports no conventional equity constituents, so there is no holdings breakdown to show. Its exposure comes from options positions rather than shares in underlying companies.

Frequently Asked Questions about GraniteShares YieldBOOST Biotech ETF (BIOY)

What is GraniteShares YieldBOOST Biotech ETF's dividend yield?
GraniteShares YieldBOOST Biotech ETF (BIOY) pays a current trailing twelve-month dividend yield of 32.81%, which works out to $6.31 per share annually based on the most recent payout schedule.
When does GraniteShares YieldBOOST Biotech ETF pay distributions?
The most recent ex-dividend date was October 30, 2026. The next scheduled dividend payment date is November 3, 2026.
What does GraniteShares YieldBOOST Biotech ETF invest in?
The GraniteShares YieldBOOST Biotech ETF, an exchange-traded fund launched by GraniteShares Inc. under the umbrella of the GraniteShares ETF Trust, is managed by GraniteShares Advisors LLC. This U.S.-domiciled fund primarily allocates capital to the public stock markets within the United States. Its investment approach involves constructing its portfolio using derivative instruments, such as options, to gain exposure to companies operating across the healthcare, pharmaceutical, biotechnology, and life sciences industries. The ETF seeks a diverse selection of both growth and value stocks,...